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Abstract 
The risk of crystallization in solutions, with a 
composition corresponding to that of urine in various 
parts of the nephron, was assessed by studying urine 
samples containing standardized increments of calcium 
and oxalate concentrations. The experiments were car-
ried out in salt solutions with and without dialysed urine 
and the appearance of crystals was detected and meas-
ured with a Coulter counter. With increased concentra-
tions of calcium, crystals of calcium phosphate were pre-
dominantly formed in solutions with a composition cor-
responding to that in the proximal and distal tubuli, 
whereas, calcium oxalate was the primary crystallization 
product in solutions with a composition corresponding to 
the collecting duct. These conclusions were based on 
calculations of ion-activity products of calcium oxalate, 
hydroxyapatite, and calcium hydrogen phosphate, at the 
first appearance of crystals; studies on crystal morpholo-
gy with scanning electron microscopy, and precipitation 
of [14C]-oxalate following addition of calcium. The ion-
activity products of calcium oxalate at the first appear-
ance of crystals following addition of oxalate to solu-
tions with a composition corresponding to the collecting 
duct were significantly lower in the presence of dialysed 
urine. This might reflect a promoting effect of some 
macromolecules on the nucleation of calcium oxalate. 
Dialysed urine in these samples also had a pronounced 
influence on the development of the crystals by markedly 
reducing the mean crystal volume during the first hour 
following the formation of 100 crystals with a diameter 
between 3.5 and 5 µm. Such an effect was not observed 
in those solutions in which calcium phosphate crystals 
had formed. 
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Introduction 
The mechanisms behind the formation of calcium 
renal stones are incompletely understood, particularly 
concerning the initial crystallization events. With sensi-
tive stone analyses, it has become apparent that a large 
proportion of these stones are composed of mixtures of 
calcium oxalate and calcium phosphate (Prien, 1955; Pak 
et al., 1971; Chambers et al., 1972; Larsson et al., 
1984a, b; Ohkawa et al., 1992). A comparison of urine 
composition in patients with different stones also showed 
that the excretion of oxalate obviously was increased in 
patients with pure calcium oxalate stones, this was usu-
ally not the case in patients with mixed stones. Stones 
containing both calcium oxalate and calcium phosphate 
appeared to be associated with other risk factors than 
stones with only calcium oxalate (Peacock et al., 1979; 
Ohman et al., 1992). 
It is reasonable to assume that the formation of 
renal stones starts as a crystallization at the nephron 
level, probably due to an interaction of the driving force 
of the supersaturated urine and the cells lining the tubuli 
or the collecting ducts. 
When we estimated the supersaturation levels of 
calcium salts in different parts of the nephron based 
upon the information in the literature (Rector, 1973; 
Koushanpour, 1976; Robertson, 1976; Tiselius et al., 
1978; Tiselius, 1982; Simpson, 1983; Kasidas and Rose, 
1986), the data indicated that the risk of calcium phos-
phate crystallization might exceed that of calcium oxal-
ate. This appeared to be the case particularly for a urine 
composition corresponding to that in proximal tubuli, 
loop of Henle, and distal tubuli. High supersaturation 
levels and a risk of precipitation of both calcium phos-
phate and calcium carbonate in the tubular system, par-
ticularly the loop of Henle, also has been reported re-
cently (Coe and Parks, 1990; Deganello et al., 1990). 
The present study was undertaken as an attempt to 
increase our understanding of the formation of crystals 
in association with increased concentrations of calcium 
and oxalate in a urine with a composition otherwise 
similar to that in the parts of the nephron. 
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Calcium mmol/1 2.78 
Magnesium mmol/1 0.09 
Phosphate mmol/1 1.00 
Oxalate mmol/1 0.010 
Citrate mmol/1 0.08 
Sodium mmol/1 139 
Potassium mmol/1 3.2 




Several salt solutions were prepared in accordance 
with the assumed ion composition of urine in the proxi-
mal tubuli (PT), the proximal part of the distal tubuli 
(DTp), the distal part of the distal tubuli (DTd), and the 
collecting ducts (CD). The compositions of these solu-
tions, which is summarized in Table 1, were based on 
data in the literature concerning ion-concentrations in 
the nephron, information on the renal handling of the 
constituents, as well as their plasma concentrations and 
excretion in urine. For these calculations, we assumed 
that the concentrations of the various urine variables in 
the glomerular filtrate were as follows: calcium: 1.5 
mmol/1; oxalate: 2 µmol/1; magnesium: 0.54 mmol/1; 
phosphate: 1.35 mmol/1; sodium: 135 mmol/1; potassi-
um: 3.8 mmol/1; citrate: 0.07 mmol/1; sulfate: 1.4 
mmol/1; and pH: 7.4 (Koushanpour, 1976; Robertson, 
1976; Cohen and Barac-Nieto, 1983; Kasidas and Rose, 
1986; Simpson, 1983). An average 24-hour volume of 
the glomerular filtrate of 180 liters was expected to be 
reduced to 36 liters at the end of PT; 28.8 liters at the 
end of Henle' s loop; 8. 6 liters at the end of DT; and 
1.44 liters at the end of CD (Koushanpour, 1976). The 
concentrations of calcium were based on a reabsorption 
of63% in PT, 23% in DTp, 11% in DTd, and 1% in CD 
(Lassiter et al., 1963; Robertson, 1976). The reabsorp-
tion of magnesium, which mainly occurs in the proximal 
part of the nephron (Walser, 1983) was roughly assumed 
to be 93% in PT and 3.5% in DT. 
The concentration of oxalate was considered to be 
affected only by the volume reduction of urine and no at-
tention was paid to any secretion or passive reabsorption 
that might occur. The reabsorption of citrate varies con-
siderably with the acid base balance, but has been 
reported to be around 75 % under normal circumstances 
(Robertson, 1976). This value was used as an estimate 
of the reabsorption of citrate in PT. The tubular re-
absorptive capacities for phosphate (Koushanpour, 1976) 
Distal tubuli Distal tubuli Collecting ducts 
prox part (DTp) dist part (DTd) (CD) 
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1.32 1.04 4.50 
0.12 0.41 3.85 
1.25 4.17 32.3 
0.013 0.04 0.32 
0.10 0.35 3.21 
82 96 106 
0.95 22.5 63.7 
4.2 13.8 20.8 
6.45 6.45 5.75 
and sulfate in PT (Koushanpour, 1976; Lingeman et al., 
1989) were assumed to be 140 and 80-90 mmol per 24 
hours, respectively. Eighty per cent of filtered sodium 
is reabsorbed in PT. Of the total filtered sodium, 9.4% 
has been reported to remain in PT, 3.3% in DT, and 
0.7% in CD (Koushanpour, 1976). The reabsorption of 
potassium in PT was considered to be 84%, with 3.8% 
of filtered potassium remaining in DTp and 27% in DTd, 
attributable to an inflow of potassium. At the end of 
CD, 91.4% of filtered potassium was assumed to be re-
absorbed (Koushanpour, 1976). 
The pH in the samples was chosen according to 
results reported by Rector (1983) with 6.7-6.8 in PT; 
6.4-6.5 in DT; and 5.6-6.0 in CD. 
These solutions were used in the crystallization 
experiments either with or without the addition of dia-
lysed urine. In order to avoid any risk of precipitation 
of ammonium salts, we added no ammonium ions to the 
solutions, despite the normal presence of this ion both in 
the distal tubuli and the collecting ducts. Because of 
technical difficulties in preparing a CD solution accord-
ing to these calculations, we used a composition of the 
CD sample described for urine by Burns and Finlayson 
(1980). 
The amount of dialysed urine added to the sam-
ples was roughly calculated from the degree of dilution 
at different nephron levels in comparison with the final 
urine. Dialysed urine was added to the PT and the DTp 
samples to give a 10% concentration of urine. The DTd 
samples were analyzed with a 20% urine concentration, 
while the CD sample was prepared by dissolving the 
necessary salts in the dialysed urine. 
Preparation of dialysed urine 
A pooled sample of urine from normal subjects 
was used as a source of macromolecules. This urine had 
been prepared according to our routine for direct deter-
mination of the risk of crystallization (Tiselius, 1985). 
This urine had been collected between IO PM and 6 AM 
in bottles containing 15 ml of 3 mmol/1 sodium azide. 
Each sample was checked for the absence of bacteria, 
Crystallization of calcium salts in the nephron 
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Figure 1. A typical result of the crystal formation in a 
sample following standardized addition of calcium. The 
recording of crystals was made in the size range 3.5 to 
5 µm in a Coulter counter 40 seconds after each addition 
of 100 µl of a 1 mol/1 calcium chloride solution. 
protein, and glucose, after which pH was adjusted to 
5. 8. The urine was subsequently centrifuged at 2800 
rpm for 30 minutes. The supernatants were decanted 
and saved, and the sediments were combined in one 
tube. Following repeated centrifugation of the sediment 
fraction, this supernatant was combined with the previ-
ously collected supernatants. The crystals in the sedi-
ment were dissolved by addition of 1 mmol/1 hydrochlo-
ric acid. After centrifugation and neutralization, this 
supernatant was combined with the other urine. 
The undissolved material in the tube was dis-
carded. The pH of the urine was now readjusted to 5.8. 
One hundred milliliter aliquots of the pooled urine were 
then transferred to Spectrapore No. 3 dialysis tubings 
with an exclusion limit of 3500 Da (Spectrum Medical 
Industries, Inc., Houston, Texas). Each tubing was 
placed in 1000 ml of deionized water with magnetic stir-
ring at room temperature. The water was exchanged 
eight times, once every hour. During the following 15 
hours, still under continuous stirring, the samples were 
kept in deionized water at +4 °C, after which the deion-
ized water was replaced by Milli-Q filtered water (Milli-
pore, S.A, Molsheim, France), exchanged six times, 
once every hour. The samples were subsequently filled 
up to the original volume with water and stored at -20°C 
until used in the experiments. 
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Determination of crystallization following addition of 
calcium chloride 
One hundred milliliter samples of the salt solu-
tions, with or without dialysed urine, were passed 
through 0.22 µm Millipore filters. A solution of calci-
um chloride was added in 100 µl fractions to the PT, 
DTd, and CD samples, and in 200 µl fractions to the 
DTp samples. Calcium chloride was added every minute 
and the number of crystals recorded 40 seconds later 
with a Coulter counter (Model ZB) equipped with chan-
nelyser (Coulter Electronics Ltd, Luton, U.K.) using a 
100 µm capillary tube. Only those crystals were consid-
ered that appeared in the size interval of 3.5 to 5.0 µm, 
and the addition of calcium was stopped when 100 crys-
tals had been recorded in a volume of 50 µl. The pH 
was maintained by repeated addition of small aliquots of 
0.05 mol/1 sodium hydroxide. 
Due to differences in the crystallizati0::-1 pwyen-
sity, two concentrations of calcium chloride were used 
in the experiments. A 1.0 mol/1 calcium chloride solu-
tion was used for PT, DTp, and DTd samples, while, a 
0. 7 mol/1 solution was used in the experiments with CD 
samples. 
A typical crystallization experiment is shown in 
Figure 1. The concentrations of the constituents of the 
samples at the first appearance of crystals, as well as at 
the formation of 100 crystals were recorded. Correc-
tions were made for changes in the volume as a result of 
crystal counting. These data were subsequently used for 
calculation of the ion-activity products of calcium oxa-
late (APcaox); hydroxyapatite (APHAP); and calcium hy-
drogen phosphate, brushite (APBru); by means of a com-
puterized iterative approximation with the EQUIL2 pro-
gram (Werness et al., 1985). The risk of crystallization 
was also expressed as the increment in calcium concen-
tration necessary for formation of crystals in the size 
range 3.5 to 5 µm. 
Determination of crystallization following addition of 
sodium oxalate 
One hundred milliliter samples of salt solutions, 
with or without dialysed urine, were passed through 0.22 
µm Millipore filters. A solution of 0.04 mol/1 sodium 
oxalate was added in 100 µl fractions to all samples. 
Sodium oxalate was added every minute and the number 
of crystals recorded 40 seconds later as described above 
for the calcium experiment (Tiselius, 1985). The con-
centrations of the constituents were recorded in a similar 
way, both at the first appearance of crystals and at the 
formation of 100 crystals in the size range 3.5 to 5 µm. 
The pH was checked before and after crystallization and 
remained constant. 
Determination of mean crystal volumes 
As soon as 100 crystals had been recorded follow-
ing addition of the calcium, the samples were kept under 
magnetic stirring during the following 60 minutes. Ali-
quots were drawn from all samples after 15 and 60 min-
utes for analysis of crystal size distribution in a Coulter 
Multisizer with a 100 µm capillary tube. The number 
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and volume of the crystals were determined in the size 
interval between 3.5 and 45 µm. The mean crystal vol-
ume (MCV) was obtained by dividing the total volume 
(µm 3) by the total number of crystals. We also calcu-
lated MCV-quotients: MCV 60/ MCV 15, to express the 
changes in crystal volume that occurred during the 
observation period. 
Microscopic examination of the crystals 
Aliquots for examination of the crystal material 
after addition of calcium chloride were obtained from 
samples treated in the same standardized way as de-
scribed above. Samples were drawn just before the ex-
pected appearance of 3.5 to 5 µm crystals in the solu-
tion. These samples were isolated for scanning electron 
microscopy (SEM) by passing them through polycar-
bonate membrane filters with a pore size of 0. 2 µm 
(Poretics corp, Livermore, CA, USA). The filters were 
rinsed with air, dried at room temperature, and mounted 
with double stick tape on metallic stubs. The crystals 
were then covered by a 10 nm layer of metallic platinum 
in a twin electron beam gun sputter coating unit 
(Edwards Model 3AM, Crawley, Sussex, U.K.). The 
crystals were examined in a JEOL JSM-840 SEM 
(Tokyo, Japan). 
Isotope-studies of crystallization 
In this experiment calcium chloride was added to 
PT, DTp, DTd, and CD samples containing 10 µCi of 
[ 14C]-oxalate per ml. The [14C]-oxalic acid solution had 
a specific radioactivity of 109 µCilµmol (Amersham, 
Buckinghamshire, U .K.). After each addition of calcium 
chloride to 100 ml of the experimental solution, aliquots 
of one milliliter were drawn for assessing the amount of 
isotope remaining in solution. After passage of the sam-
ple through a 0.22 µm Millipore filter, 0.5 ml was im-
mediately added to 10 ml of scintillation fluid (Maxi-
fluor, J T Baker BY, Deventer, Netherlands). The iso-
tope concentration was measured in a liquid scintillation 
spectrometer (LKB Wallac 1217, Turku, Finland). 
Quench correction was performed by means of an inter-
nal standard. 
Calculations of ion-activities 
For calculation of the ion-activity product of HAP 
we used the structure Ca 5(PO 4))(OH). 
Statistics 
Mann-Whitney U test were used for sample 
comparisons. 
Results 
The ion-activity products of calcium oxalate 
(APcaox) at the first appearance of crystals in salt 
solutions, with and without dialysed urine, following 
addition of calcium, are presented in Table 2. The 
saturation with respect to CaOx was very low in all 
solutions except in the CD samples. With a thermody-
namic solubility product for CaOx of 0.23 to 0.25 x 10-8 
M2 (Pak et al., 1975; Tomazic and Nancollas, 1979), it 
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is evident that the APcaox values in both PT and DTp 
samples were below that level. These solutions were 
thus undersaturated with CaOx at the time of crystal 
formation, and the only type of crystal observed in PT 
and DTp samples was calcium phosphate. Although the 
APcaox in DTd samples was above the solubility prod-
uct, this supersaturation is certainly too low to be 
associated with a nucleation of CaOx. In contrast, the 
CD samples were highly supersaturated with CaOx. 
The APHAP values corresponding to the first ap-
pearance of crystals as well as when 100 crystals with 
diameters between 3.5 and 5 µm were recorded, are 
given in Table 3. The lowest supersaturation levels as-
sociated with the formation of calcium phosphate crys-
tals was observed in the DTd samples. The formation 
product of HAP is unknown, but the APHAP values in all 
samples were considerably above the solubility product 
for HAP, which is reported to be approximately 2 .4 x 
10-59 M9 (Koutsoukos and Nancollas, 1981). 
The pH levels in the nephron are consistent with 
precipitation of calcium hydrogen phosphate and in as 
much as some crystals observed in the PT, DTp, DTd, 
and CD samples, 60 minutes after the end point in the 
calcium experiments, had a brushite-like appearance, we 
also calculated the AP 8 ru in the different samples (Table 
4). Although the supersaturation with this salt was be-
low the reported formation product [2 x 10-7 (mol/1)2], 
the values exceeded the solubility product of 0.9 to 1.3 
x 10-7 (Koutsoukos and Nancollas, 1981; Nancollas, 
1982) in PT, DTp, and DTd samples. The AP8 ru at the 
first appearance of crystals were significantly lower in 
DTp-samples with dialysed urine (p < 0.01) and higher 
in CD-samples with dialysed urine (p < 0.01). 
The ion-activity products of CaOx, HAP and 
brushite at the crystallization that followed increased 
concentrations of oxalate are shown in Tables 5, 6 and 
7. In all solutions, except in the CD samples, the 
APcaox required for oxalate induced crystallization was 
significantly higher (p < 0.01) than that associated with 
crystallization following addition of calcium. The 
APHAP and AP8 ru levels recorded at crystallization fol-
lowing addition of oxalate were significantly lower (p < 
O.Ol) than those observed following addition of calcium. 
The risk of crystallization expressed as the rela-
tive increment in the concentrations of calcium and oxa-
late, required for the formation of crystals in the indi-
vidual solutions, is shown in Table 8. It is evident that 
a great risk of crystallization following addition of cal-
cium occurred in PT, DTd, and CD samples, while CD 
samples showed the greatest risk following the addition 
of oxalate. In the PT and DT samples, a much higher 
relative increment in the concentration of oxalate than of 
calcium was necessary to induce crystal nucleation. 
The concentration of [14C]-oxalate remaining in 
solution at several concentrations of calcium is shown in 
Figure 2. There was evidently a marked precipitation of 
oxalate only in the CD samples, with a consumption of 
isotope in PT, DTp, and DTd samples, with or without 
urine, of less than 5 % . There was, however, a marked 
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Figure 2. Per cent of [14C]-oxalate remaining in solution following addition of calcium to solutions without and 
with dialysed urine. The arrows point to calcium concentrations where crystals first appeared in the Coulter 
counter experiments. 
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Table 2. Ion-activity products of calcium oxalate (APcaox) at different points of crystallization in the experiments in 
which calcium was added. 
108 X M2 
Before calcium addition 
Mean (Standard deviation, SD) 
At first appearance of crystals 
in the size range 3.5-5 J.Lm 
At 100 crystals 
in the size range 3. 5-5 J.Lm 
At first appearance of crystals 
in the size range 3.5-5 J.Lm 
At 100 crystals 





n = 10 
o. 11 co.oo6r 
0.09 (0.003)m 




Without dialysed urine 
0.10 (O.Ol)m 0.63 (O.Ol)m 
0.09 (O.Ol)m 0.63 (0. lO)'n 
n = 10 n = 10 
Wirh. dialysed urine 
0.12 (0.08)m 0.63 (0.14)m 
0.10 (0.0l)m 0.62 (0.15)m 
n = 10 n = 10 





n = 11 
4.22 (0.06) 
4.18 (0.07) 
n = 9 
Table 3. Ion-activity products of hydroxyapatite (APHAP) at different points of crystallization in the experiments in 
which calcium was added. 
Before calcium addition 
Mean (SD) 
At first appearance of crystals 
in the size range 3. 5-5 J.Lm 
At 100 crystals 
in the size range 3.5-5 J.Lm 
At first appearance of crystals 
in the size range 3. 5-5 J.Lm 
At 100 crystals 
in the size range 3.5-5 J.Lm 
PT 
3.40 X 10-4? 
2.17 X 10-42 
(1.36 X 10-42)m 
6.56 X 10-42 
( 1. 78 X 10-42)m 
n = 10 
2.58 X 10-42 
(1.06 X 10-42)m 
7.93 X 10-42 
(1.38 X 10-42)'n 
n = 10 
Samples 
DTp DTd 
2.29 X 10-50 7.85 X 10-50 
Without dialysed urine 
0.86 X 10-42 2.08 X 10-44 
(0.43 X 10-42)m (1.87 x 10-44)m 
J .37 X 10-42 
(0. 70 X J0-42)'n 
n = 10 
6.00 X 10-44 
(4.06 10-44)m 
n = 10 
With. dialysed urine 
0.29 X 10-42 3.06 X 10-44 
(0.13 X 10-42rn,b (2.75 X 10-44)m 
0.87 X 10-42 
(0.26 X J0-42)m,b 
n = 10 
10. 8 X 10-44 
(7.52 X 10-44)m 
n = 10 
Compared with samples without dialysed urine: bp < 0.01; 
Compared with samples following addition of oxalate: mp < 0.01 
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CD 
3.66 X 10-49 
0.61 X 10-45 
(0. 22 X 10-45)m 
2.11 X 10-45 
(0.51 X 10-45)m 
n = 11 
1.97 X 10-45 
(0.24 X 10-45)m 
7.22 X 10-45 
(0.47 X 10-4S)m 
n = 9 
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Table 4. Ion-activity products of calcium hydrogen phosphate (APBru) at different points of crystallization in the 
experiments in which calcium was added. 
107 X M2 
Before calcium addition 
Mean (SD) 
At first appearance of crystals 
in the size range 3.5-5 µm 
At 100 crystals 
in the size range 3.5-5 µm 
At first appearance of crystals 
in the size range 3.5-5 µm 
At 100 crystals 
in the size range 3.5-5 µm 
PT 
0.87 
5.58 (0. !6)m 
6.20 (0.18)m 
n = 10 
5.53 (0.26)m 
6.28 (o. 13r 




Without dialysed urine 
7.23 (0.3l)m 
7.76 (0.24)m 
n = 10 
7.50 (l. l 7)m 
9.39 (0.82)m 
n = 10 
With dialysed urine 
6.52 (0.21r,a 
7.28 (0.19)m,a 
n = 10 
7.99 (l.56)m 
10.43 (l.06)m,a 
n = 10 
Compared with samples without dialysed urine: ap < 0.05; bp < 0.01 
Compared with samples following addition of oxalate: mp < 0.01 
CD 
4.21 
17. 1 (I. lO)m 
21.6 (l.lO)m 
n = 11 
20.7 (0.32)m,a 
26. I (0.40)m,a 
n = 9 
Table 5. Ion-activity products of calcium oxalate (APcaox) at different points of crystallization in the experiments in 
which oxalate was added. 
108 X M2 
Before oxalate addition 
Mean (SD) 
At first appearance of crystals 
in the size range 3.5-5 µm 
At 100 crystals 
in the size range 3.5-5 µm 
At first appearance of crystals 
in the size range 3.5-5 µm 
At 100 crystals 
in the size range 3.5-5 µm 
PT 
0.103 
4.94 (l .05)m 
6.49 (0.27)m 
n = 10 
3.97(0.!7)m 
5.20 (l.03)m,a 




Without dialysed urine 
4.38 (0.90)m 4.05 (0.8l)m 
4.97 (0.78)m 4.51 (0.7l)m 
n = 10 n = 10 
With dialysed urine 
4.85 (0.94)m 3.87 (0.85)m 
5. 65 (0. 86)m 4.38 (0.84)m 
n = 10 n = 10 
Compared to samples without dialysed urine: 8p < 0.05; 






n = 10 
5.01 (0.23t 
5.62 (0.41) 
n = 10 
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Table 6. Ion-activity products of hydroxyapatite (APHAP) at different points of crystallization in the experiments in 
which oxalate was added. 
Before oxalate addition 
Mean (SD) 
At first appearance of crystals 
in the size range 3.5-5 µm 
At 100 crystals 
in the size range 3.5-5 µm 
At first appearance of crystals 
in the size range 3. 5-5 µm 
At 100 crystals 
in the size range 3.5-5 µm 
PT 
3.40 X 10-47 
2.46 X 10-47 
(0.18 X 10-47)m 
2.21 X 10-47 
(0.04 X 10-47 )m 
n = 10 
2.63 X 10-47 
(0.03 X 10-47)m 
2.42 X 10-47 
(0. 17 X 10-47)m 
n = 10 
Samples 
DTp DTd 
2.29 X 10-50 7.85 X 1O-50 
Without dialysed urine 
1.33 X 10-50 4.16 X 10-50 
(0.16 X 10-50)m (0.61 X 10-50)m 
1.23 X 10-50 
(0.13 X 10-50)m 
n = 10 
3.83 X 10-50 
(0.50 X 10-50)m 
n = 10 
With dialysed urine 
1.25 X 10-50 4.30 X 10-50 
(0. 16 X 10-50)m (0.66 X 1O-50)m 
1. 12 X 1 o-50 
(0.13 X 10-50)m 
n = 10 
3.93 X 10-50 
(0.59 X 10-50)m 
n = 10 
Compared to samples following addition of calcium: mp < 0.01. 
CD 
3.66 X 10-49 
3.19 X 10-49 
(0.08 X 10-49)m 
3.12 X 10-49 
(0.03 1O-49)m 
n = 10 
3.23 X 10-49 
(0.04 X 10-49 )m 
3.13 X 10-49 
(0.07 X 10-49 )m 
n = 10 
Table 7. Ion-activity products of calcium hydrogen phosphate (AP 8 ru) at different points of crystallization in the 
experiments in which oxalate was added. 
Before oxalate addition 
Mean (SD) 
At first appearance of crystals 
in the size range 3.5-5 µm 
At 100 crystals 
in the size range 3.5-5 µm 
At first appearance of crystals 
in the size range 3.5-5 µm 
At 100 crystals 





n = 10 
0.83 (O.OO2)m 
0.82 (0 OOl)m 




Without dialysed urine 
0.42 (O.Ol)m 0.66 (O.O2)m 
0.41 (O.Ol)m 0.65 (O.O2)ffi 
n = 10 n = 10 
With dialysed urine 
0.41 (O.Ol)m 0.67 (O.O2)m 
0.40 (O.Ol)m 0.66 (O.O2)m 
n = 10 n = 10 






n = 10 
4.08 (O.Ol)m 
4.06 (O.O2)m 
n = 10 
Crystallization of calcium salts in the nephron 
Table 8. Increments in the concentrations of calcium (A calcium) and oxalate (A oxalate) necessary for detection of 
crystals in the size range 3.5 to 5 µm in samples without and with (dU) dialysed urine. The relative increment was 
expressed as the quotient between the A calcium and the initial calcium concentration and between A oxalate and the 
initial oxalate concentration, respectively. 
Calcium addition 
A calcium Relative 
mmol/1 increment 
PT 30.3 (2.0) 10.9 
DTp 50.5 (5.8) 38.2 
DTd 9.8 (2.0) 9.4 
CD 7.5 (1.1) I. 7 
PT+ dU 29.8 (3.1) 10.7 
DTp + dU 39.3 (3.6) 29.8 
DTd + dU 10. 7 (2. 7) 10.3 
CD+ dU 11.0(3.1) 2.4 
difference in the crystallization of CaOx when the CD 
samples, with and without dialysed urine, were com-
pared, with a much slower precipitation of oxalate in the 
presence of urine. 
Scanning electron microscopy of the precipitate 
close to the first appearance of crystals in the size-range 
3.5 to 5 µm showed that calcium phosphate, was proba-
bly the only early material in PT, DTp and DTd sam-
ples, following addition of calcium (Figures 3 and 4). 
In CD samples, with and without dialysed urine, CaOx 
was the only early crystal phase. When DTd and CD 
samples were further supersaturated by addition of cal-
cium until 100 crystals in the size range 3.5 to 5 µm had 
formed, brushite crystals were frequently observed after 
60 minutes. 
The MCV following addition of calcium (Table 9) 
increased between 15 and 60 minutes with a factor of 1.6 
to 5.5 in PT, DTp and DTd samples without dialysed 
urine. The corresponding figures in samples containing 
urine were 1.2 to 2.5. However, a most pronounced dif-
ference was recorded in the CD experiments, in which 
the MCV markedly increased in the absence of dialysed 
urine 36. l compared with 1.04. 
Discussion 
It is reasonable to assume that renal stones com-
posed of calcium salts start by a heterogeneous nuclea-
tion in a metastably supersaturated urine. Such a crys-
tallization can theoretically be induced by free particles 
in the solution or by the surfaces of cells lining the col-
lecting system, with or without a contribution of macro-
molecules (Vermeulen and Lyon, 1968; Finlayson and 
Reid, 1978; Finlayson, 1979; Rushton et al., 1981; 
Hering et al., 1989). The most frequent constituent of 
renal calcium stones is calcium oxalate and a recent 
analysis of the composition of non-infection calcium 
stones among our own patients revealed that whereas, 
99 % of calcium stones contained calcium oxalate, as 
55 
Oxalate addition 
A oxalate Relative 
mmol/1 increment 
0.49 (0.1) 49.0 
0.60 (0.14) 45.9 
1. 15 (0.26) 28.8 
0.57 (0.01) 1. 8 
0.39 (0.02) 38.7 
0.67 (0.14) 51.3 
1.08 (0.27) 27.0 
0.52 (0.04) 1.6 
Table 9. Mean (SD) of the mean crystal volumes 
(MCV) and MCV-quotients at different ti mes after for-
mation of 100 crystals with a diameter between 3.5 and 
5 µm following increment of the calcium concentration 






DTp + dU 
DTd + dU 
CD+ dU 
MCV 15 min MCV 60 min 
µm3 µm3 
92.6 (22.4) 192.1 (56.6) 
62. 6 ( 13. 6) 351.2 (306.1) 
71.3 (38.5) 93.3 (30.9) 
65.2 (10.5) 2161 (1405) 
56.5 (11.2) 110 (20.3) 
63.4 (11.6) 158 (56. 7) 
91. 8 ( 4 7. 7) 93.3 (52.1) 











"p < 0.02 compared to samples with dialysed urine. 
many as 74% were mixtures of calcium oxalate and cal-
cium phosphate (unpublished results). Information on 
the early steps of the formation of mixed calcium oxa-
late/calcium phosphate stones is insufficient due to 
experimental difficulties, and there is no agreement on 
whether calcium phosphate (Pak, 1969; Zarembski and 
Grieve, 1976; Baumann, 1985; Lanzalaco et al., 1988; 
Achilles et al., 1992) or calcium oxalate (Lonsdale, 
1968; Finlayson, 1974; Sutor et al., 1974; Hodgkinson, 
1977; Hartung and Leskovar, 1978) constitutes the 
primary nucleus. 
Methodological remarks 
The composition of the solutions was chosen to 
correspond to an average composition of the urine in the 
respective parts of the nephron. This is undoubtedly an 
over-simplification because the composition of urine is 
J. Luptak et al. 
... 
~ .J"l,.,. s - . A ,. ,. ,,,,,.. 
;,.,r..,___ 




• ,.. ,,. ,. ,. - ,. 1111 " .. ,_ ,. /J - ,.. ,.. .. ---- .. • -
lD ,'- ,... ,Jilt , ,,. , 
.-. ,,... ,.. 
--: .... ,. 
--,. ,... ,.. ~ ,.-
""' .,,, :-~ ,,. .,.. 
tit\ 
...,._ ,. " ~ .... ~ ,.. ,. 
<. ,,. -- -,,. ,. .... -- ~ ,. 
,. ... f\ ,. ,. .. -.....- - ,.. 
Figure 3. Scanning electron micrographs of the precipitate initially formed following addition of calcium to a PT sam-
ple without (A) and with (B) dialysed urine and a DTp sample without (C) and with (D) dialysed urine. Bars = 1 µm. 
subject to a constant change during its passage through 
the nephron. The most pronounced alteration probably 
occurs during the concentration in the collecting duct 
and although the composition in the proximal part of the 
collecting duct is similar to that in the distal part of the 
distal tubuli, the composition in the distal part of the 
collecting duct will be similar to the final urine. To 
cover the whole range of supersaturation in the neph ron, 
we used a composition of the CD samples approximately 
corresponding to that in the final urine. 
Dialysed urine was added as a source of urinary 
macromolecules. We added dialysed urine in an amount 
that very roughly corresponded to the dilution in the 
nephron relative to the final urine. Both PT and DTp 
samples were used with a 10% concentration of dialysed 
urine, which for PT probably means a slightly higher 
concentration of macromolecules than that encountered 
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physiologically, but no important differences were ob-
served between samples with and without dialysed urine. 
Although dialysed urine is an excellent source of 
urinary macromolecules, it had two major drawbacks in 
these experiments. Firstly, we paid no attention to the 
fact that some of the macromolecules are not normally 
present at all levels of the nephron (Coe et al., 1991 a,b; 
Hess, 1992), and secondly, macromolecules admixed 
during the storage in the bladder might influence the 
crystallization in a way that differs from the physio-
logical situation (Martin et al., 1985; Edyvane, 1986). 
This can, to some extent, be compensated for by adding 
pure preparations of known crystallization modifiers 
such as nephrocalcin (Coe et al., 199 la, b), Tamm-Hors-
fall mucoprotein (Rose and Sulaiman, 1982; Yoshioka et 
al., 1989; Coe et al., 199 la,b; Hess, 1992), and uropon-
tin (Hoyer, 1992), but such an approach might also be 
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Figure 4. Scanning electron micrographs of the precipitate initially formed following addition of calcium to DTd sam-
ple without (A) and with (B) dialysed urine and a CD sample without (C) and with (D) dialysed urine. Bars = 1 µm. 
insufficient because all macromolecules that affect the 
crystallization process are not yet identified (Atmani et 
al., 1993). We made no attempt to assess quantitatively 
the effect of urinary macromolecules, and for this rea-
son, we used a urine-pool from normal subjects that was 
available. Although acidification of the sediment might 
damage a small fraction of urinary macromolecules, such 
a mechanism is probably of less significance for the con-
clusions in this study. 
The ion activity products in the various solutions 
were calculated by means of repeated approximation 
with the EQUIL2 program (Werness et al., 1985). No 
corrections were made for the complex-formation 
between the several ions and urinary macromolecules 
(Gill et al., 1977; Lian et al., 1977; Morse and Resnick, 
1989; Nishio et al., 1990), and the ion-activity products 
obtained for the samples with dialysed urine might, 
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therefore, in reality, be lower than the values presented. 
This effect is probably less important for the low con-
centrations of dialysed urine present in the PT and DT 
samples, but is certainly more important with the high 
urine concentration used in the CD samples. On the 
other hand, it is likely that the macromolecules affect 
the ion activities in a similar way before and after addi-
tion of calcium and oxalate. 
The calculated estimates of APcaOx• APHAP and 
APBru for the solution composition at the first appear-
ance of crystals should not be taken for an estimate of 
the formation product because in our Coulter counter 
measurements, no particles were detected until they had 
increased to a diameter of at least 3.5 µm. This should 
be considered in view o(the fact that the critical cluster 
size for calcium oxalate has been estimated to be 13 A 
(Walton, 1967) and that of amorphous calcium phosphate 
J. Luptak et al. 
9. 8 A (Nancollas, 1982). Crystals were microscopically 
detected already at a calcium concentration in the CD 
sample of approximately 5 mmol/1 which corresponds to 
an APcaox of 2.13 x 10-8. The recorded levels of 
APHAP• APBru and APcaox at the first experimental evi-
dence of crystal formation are, however, presumably 
proportional to the actual formation products of the 
salts. 
Furthermore, both calcium and oxalate were 
added in a standardized way during a limited period of 
time, during which a rapid precipitation was necessary 
for detection of the crystallization. It should also be 
emphasized that the experiments were carried out in the 
absence of particulate material (with a diameter above 
0.22 µm) that normally might be present in the nephron 
urine and also without the cellular lining that probably 
is important for establishment of a fixed particle crystal-
lization (Finlayson and Reid, 1978; Rushton et al., 
1981; Hering et al., 1989; Kohri et al., 1991; Mandel 
and Riese, 1991). 
It needs to be emphasized that the reproducibility 
in non-seeded crystallization systems is inferior to that 
in seeded systems (Nancollas, 1983). For this reason, 
between 9 and 11 experiments were performed with each 
solution. Overall, the reproducibility was best in the 
calcium experiments. The coefficients of variation for 
the increment of calcium at the first appearance of crys-
tals in the pure salt solutions varied between 6.5 and 
20.5%, and in solutions with dialysed urine between 9.2 
and 28.5 % . The corresponding figures following addi-
tion of oxalate were between 2. 3 and 23. 0 % , and be-
tween 4.4 and 25 .1 % , respectively. Although considera-
ble, this variation is acceptable in this type of experi-
ments. 
The variability in APHAP necessary for inducing 
nucleation of calcium phosphate is remarkable but can 
possibly be explained either by the different calcium/ 
phosphate or calcium/citrate ratios in the different solu-
tions leading to different kinetics and different size 
distributions during the early phase of the crystal forma-
tion process. 
Formation of crystals in PT and DTp-samples 
The measurements in this investigation showed 
that in solutions with a composition corresponding to 
that in the proximal and distal tubuli, there was a greater 
risk of forming crystals of calcium phosphate than of 
calcium oxalate. This was in accordance with the super-
saturation levels assumed to occur in urine at these lev-
els of the nephron. Although an increased concentration 
of oxalate resulted in nucleation of calcium oxalate, the 
relative increment in oxalate required for crystal forma-
tion was higher than the relative increment of calcium. 
Although crystals of calcium oxalate have been observed 
at high levels of the nephron in animal experiments, this 
was always seen in association with a considerable load 
of oxalate (Kawada et al., 1976; Khan er al., 1979; 
Rushton er al., 1981; Buck and Reis-Santos, 1990). 
Very high relative increments were recorded for 
oxalate in order to induce crystallization in PT and DTp 
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samples, and although the nucleation in reality starts at 
lower concentrations than those determined with this 
technique, it is reasonable to assume that the risk of cal-
cium oxalate crystallization in these parts of the nephron 
normally is extremely low. 
In a recent study based on micropuncture studies 
in animals, it was concluded that the loop of Henle was 
at particular risk for precipitation of calcium phosphate 
as well as of calcium carbonate (Coe and Parks, 1990; 
Deganello et al., 1990). We have not carried out any 
measurements with a composition corresponding to that 
in the loop of Henle, but have assumed that the risk of 
crystallization in this part of the nephron might be be-
tween that in PT and DTp, nor did we include CO 2 in 
our calculations. Although this factor is fundamental for 
determination of the risk of calcium carbonate nuclea-
tion, its effect on calcium phosphate is negligible. It is 
possible, however, that the counter current system in 
this part of the nephron brings about changes in urine 
composition that are difficult to predict. 
Formation of crystals in DTd and CD samples 
The increment in concentrations of calcium and 
oxalate necessary for appearance of crystals in DTd and 
CD samples were lower than those in PT and DTp sam-
ples. There were several observations supporting the 
conclusion that the risk of calcium phosphate formation 
in the DTd samples was higher than that of calcium oxa-
late. A higher relative increment of oxalate than of 
calcium was required to start the crystallization. In 
addition, calcium phosphate was the predominant crystal 
phase, at least early after the first appearance of crys-
tals. Furthermore, there was no detectable reduction in 
the concentration of 14C-oxalate remaining in solution, 
when the concentration of calcium was increased beyond 
the point of nucleation (Figure 2). 
With the composition of the CD samples used in 
these experiments, calcium oxalate was the predominant 
crystal phase observed irrespective of whether oxalate or 
calcium were added. The pH is certainly an important 
determinant of crystal formation at increased concentra-
tions of calcium under these conditions. We used a pH 
of 5.75, which might be an acceptable estimate of the 
average pH of urine at this nephron level. The higher 
pH following meals, and seen in association with acidifi-
cation defects, will probably increase the risk of calcium 
phosphate rather than calcium oxalate nucleation also in 
this part of the nephron. 
The increments in the concentrations of oxalate 
necessary to get an AP caox at the level of the forma-
tion product (around 2 x 10-8 M2) would be approxi-
mately 0.20, 0.26, 0.55 and 0.32 mmol/1 for solutions 
with compositions corresponding to urine in the proxi-
mal tubuli, the proximal part of the distal tubuli, the 
distal part of the distal tubuli, and the collecting duct. 
It is not likely that these concentrations will occur phys-
iologically except in the collecting duct. Crystal nuclea-
tion on a surface with a suitable promoting lattice may, 
however, be possible at lower levels of supersaturation. 
Crystallization of calcium salts in the nephron 
The inhibiting influence of macromolecules on the 
further development of crystals in the CD samples is 
evident from the great difference in MCV-quotients 
between pure salt solutions and salt solutions with 
dialysed urine. A similar effect was not observed in 
those samples in which calcium phosphate was the 
primary product of crystallization. 
Some factor in the dialysed urine might act as a 
promoter of calcium oxalate precipitation. Such a mech-
anism has previously been suggested by other authors 
(Phaneuf-Mimeault and Tawashi, 1977; Hallson and 
Rose, 1979; Burns and Finlayson, 1980; Werness et al., 
1981; Drach et al., 1982; Rose and Sulaiman, 1984; 
Khan et al., 1988; Morse and Resnick, 1989; Hackett et 
al., 1990; Nishio et al., 1990) and is furthermore sup-
ported by the lower APcaox required for CaOx crystal 
formation in the presence of dialysed urine following 
addition of oxalate (Table 5). 
There was a higher AP caox recorded at the first 
appearance of crystals in the CD sample following addi-
tion of oxalate in comparison with that following addi-
tion of calcium, despite the fact that calcium oxalate 
crystals were formed in both experiments. The calcium/ 
citrate ratio might thereby have influenced the early 
development of crystals, that is, in the size range below 
3.5 µm. It should be observed that the calcium/citrate 
ratio in the CD sample without urine was 1.40 at the 
first appearance of crystals following addition of oxalate 
and 3. 74 following addition of calcium. A higher con-
centration of free citrate relative to the concentration of 
calcium might have increased the aggregation inhibition 
resulting in smaller particles and a later appearance of 
crystals in the size range above 3.5 µm. However, cal-
cium oxalate was the major crystal phase, both in the 
calcium and the oxalate experiments. 
Although calcium oxalate undoubtedly was the 
predominant crystal phase in CD-samples, brushite crys-
tals were later observed following further addition of 
calcium . This is consistent with the supersaturation 
levels of brushite encountered at the first appearance of 
crystals in these samples. Brushite crystals apparently 
occurred later than calcium oxalate crystals in as much 
as their presence increased during storage of the sample. 
Brushite crystals were found in DTd samples in which 
APBru was above the solubility product, but below the 
formation product. A proceeding crystallization during 
preparation of the samples for microscopy might have 
lowered the pH and further increased the supersatura-
tion. 
Irrespective of whether the primary nucleus is 
amorphous calcium phosphate or brushite, it can be 
stated that calcium phosphate is the crystal that most 
easily will form in the distal tubuli. 
Possible clinical significance of the observations 
On the condition that our assumptions on the urine 
composition in various parts of the nephron are reasona-
bly correct, the results of the reported experiments lead 
to some interesting speculations on the initial steps of 
calcium oxalate stone formation. A high concentration 
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of calcium at the end of the distal tubuli, in the begin-
ning of the collecting duct, or at both places, might re-
sult in the precipitation of calcium phosphate. This pre-
cipitate could then adhere to the surface of the nephron 
cells. Following a slow migration to a lower level of the 
collecting duct, these calcium phosphate crystals might 
be able to induce nucleation of calcium oxalate in case 
of a sufficiently high supersaturation level and a pH 
below 6.5. The crystallization might occur either as a 
heterogeneous growth of calcium oxalate directly on the 
crystals of calcium phosphate or by a nucleation of calci-
um oxalate induced by the macromolecules adsorbed to 
this material. The simultaneous nucleation of brushite 
in the collecting duct urine might add further calcium 
phosphate to the precipitate and also provide additional 
promoting nuclei for calcium oxalate crystallization. 
There is so far insufficient evidence for proof of such a 
hypothesis, but the results obtained in this study clearly 
show that the complexity of calcium oxalate stone forma-
tion most certainly cannot be disentangled by only re-
garding the crystallization properties in samples of 
whole urine. 
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Discussion with Reviewers 
W.G. Robertson: Based on the authors' data, it would 
seem unlikely that hypercalciuria per se can be consider-
ed as a major cause of crystal formation in most parts of 
the nephron. What is the importance of hypercalciuria 
in calcium stone disease? 
Authors: The increase in calcium concentrations neces-
sary for crystal formation in PT and DTp samples indi-
cates that a crystallization of calcium phosphate induced 
by hypercalciuria certainly is low at these levels. Also 
in DTd and CD samples, it ·was necessary to increase 
markedly the concentration of calcium in order to record 
J. Luptak et al. 
crystal formation, although the relative increment at 
these concentration levels was much lower than in DTp-
samples. No conclusions can be drawn, however, on the 
calcium concentration required for nucleation, because 
our method did not detect crystals until they had 
achieved a diameter of at least 3.5 µm. Therefore, the 
calcium concentration recorded for the first appearance 
of crystals is much higher than that necessary for nuclea-
tion. The methods for assessing crystallization are not 
sensitive enough to decide on the role of hypercalciuria. 
The results, however, demonstrate that if an increased 
excretion of calcium is of importance at these levels of 
the nephron, then calcium phosphate is the most likely 
product of crystallization in the distal tubuli. The risk 
of calcium oxalate crystallization increases as the urine 
moves further down the nephron in a direction towards 
the distal part of the collecting duct. 
W. G. Robertson: The activity products necessary to 
produce crystallization of both calcium oxalate and cal-
cium phosphate seem much higher than anticipated from 
some other studies. What explanation do the authors 
have for this observation? 
62 
Authors: The explanation for this phenomenon should 
also be sought in the methodology. Both calcium and 
oxalate were added to the solutions in a standardized 
way to facilitate a comparison between different sam-
ples. In addition to the fact that no crystals with a diam-
eter below 3.5 µm were recorded with the Coulter count-
er technique, the samples were supersaturated to a high-
er level than that required for the formation of a critical 
nucleus of approximately 10 to 13 A. The recorded ion-
activity products are not estimates of the formation prod-
ucts but they will hopefully reflect a process that actual-
ly starts at much lower level of supersaturation. It is 
important to emphasize, however, that the concentration 
of calcium and oxalate necessary for forming a 3. 5 µm 
crystal is highly dependent upon the kinetics of crystal 
growth and crystal aggregation during the early phase of 
crystallization. Based on the preliminary data reported 
above, studies are now in progress aiming at a more ac-
curate assessment of the risk of calcium oxalate and cal-
cium phosphate in solutions with a composition corre-
sponding to that in the distal part of the distal tubu!i and 
in different parts of the collecting duct. Only following 
such experiments will it be possible to draw any conclu-
sions on the clinical significance of the risk of calcium 
phosphate and calcium oxalate nucleation at these levels 
of the nephron. 
